1887

Chapter 13 : Automated Immunoassay Analyzers

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Automated Immunoassay Analyzers, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817961/9781555811891_Chap13-1.gif /docserver/preview/fulltext/10.1128/9781555817961/9781555811891_Chap13-2.gif

Abstract:

Enzyme immunoassays (EIA) have great potential for automation in diagnostic microbiology laboratories, and a number of semiautomated and fully automated immunoassay analyzers are now commercially available for the performance of a variety of viral, bacterial, fungal, and parasitic antibody and/or antigen detection tests. The majority of the automated immunoassay analyzers provide walk-away simplicity to perform assays from sample processing through interpretation of results. The instruments can automatically generate work lists of specimens to be tested, pipette specimens from primary tubes and dilute the samples, dispense all reagents, time the incubations at a desired temperature, shake the assay vessels if needed, perform washes, and read and store the final results. The use of automated immunoassay analyzers can be advantageous to the laboratory that has a shortage of trained medical technologists or that needs to reduce costs or improve the throughput and turnaround time for test results.

Citation: Hodinka R. 2002. Automated Immunoassay Analyzers, p 324-335. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch13

Key Concept Ranking

Hepatitis C virus
0.52813894
Hepatitis delta virus
0.51213473
Enzyme Immunoassay
0.48117253
Hepatitis B
0.42222223
0.52813894
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817961.chap13
1. Abbott, G. G.,, J. W. Safford,, R. G. MacDonald,, M. C. Craine,, and R. R. Applegren. 1990. Development of automated immunoassays for immune status screening and serodiagnosis of rubella virus infection. J. Virol. Methods 27:227239.
2. Azevedo-Pereira, J. M.,, M. H. Lourenco,, F. Barin,, R. Cisterna,, F. Denis,, P. Moncharmont,, R. Grillo,, and M. O. Santos-Ferreira. 1994. Multicenter evaluation of a fully automated screening test, VIDAS HIV 1+2, for antibodies to human immunodeficiency virus type 1 and 2. J. Clin. Microbiol. 32:25592563.
3. Blackburn, C. W.,, L. M. Curtis,, L. Humpheson,, and S. B. Petitt. 1994. Evaluation of the Vitek Immunodiagnostic Assay System (VIDAS) for the detection of Salmonella in foods. Lett. Appl. Microbiol. 19:3236.
4. Bonanni, P.,, G. C. Icardi,, A. M. Raffo,, M. Ferrari Bravo,, A. Roccatagliata,, and P. Crovari. 1996. Analytical and laboratory evaluation of a new fully-automated third generation enzyme immunoassay for the detection of antibodies to the hepatitis C virus. J. Virol. Methods 2:113122.
5. Brokenshire, M. K.,, P. J. Say,, A. H. van Vonno,, and C. Wong. 1997. Evaluation of the microparticle enzyme immunoassay Abbott IMx Select Chlamydia and the importance of urethral site sampling to detect Chlamydia trachomatis in women. Genitourin. Med. 73:498502.
6. Burgisser, P.,, F. Simon,, M. Wernli,, T. Wust,, M. F. Beya,, and P. C. Frei. 1996. Multicenter evaluation of new double-antigen sandwich enzyme immunoassay for measurement of anti-human immunodeficiency virus type 1 and type 2 antibodies. J. Clin. Microbiol. 34:634637.
7. Candolfi, E.,, R. Ramirez,, M. P. Hadju,, C. Shubert,, and J. S. Remington. 1994. The Vitek immunodiagnostic assay for detection of immunoglobulin M toxoplasma antibodies. Clin. Diagn. Lab. Immunol. 1:401405.
8. Chernesky, M. A.,, D. Jang,, J. Sellors,, P. Coleman,, J. Bodner,, I. Hrusovsky,, S. Chong,, and J. B. Mahoney. 1995. Detection of Chlamydia trachomatis antigens in male urethral swabs and urines with a microparticle enzyme immunoassay. Sex. Transm. Dis. 22:5559.
9. Costongs, G. M.,, R. J. van Oers,, B. Leerkens,, W. Hermans,, and P. C. Janson. 1995. Evaluation of the Abbott automated random, immediate and continuous access immunoassay analyzer, the AxSYM. Eur. J. Clin. Chem. Clin. Biochem. 33:105111.
10. Costongs, G. M.,, R. J. van Oers,, B. Leerkes,, and P. C. Janson. 1995. Evaluation of the DPC IMMULITE random access immunoassay analyzer. Eur. J. Clin. Chem. Clin. Biochem. 33:887892.
11. Dennehy, P. H.,, T. E. Schutzbank,, and G. M. Thorne. 1994. Evaluation of an automated immunodiagnostic assay, VIDAS Rotavirus, for detection of rotavirus in fecal specimens. J. Clin. Microbiol. 32:825827.
12. Diepersloot, R. J.,, Y. van Zantvliet-Van Osstrom,, and C. A. Gleaves. 2000. Comparison of a chemiluminescent immunoassay with two microparticle enzyme immunoassays for detection of hepatitis B virus surface antigen. Clin. Diagn. Lab. Immunol. 7:865866.
13. Doche, C.,, M. Thome,, I. Dimet,, and J. Bienvenu. 1996. Evaluation of the fully automated Cobas Core enzyme immunoassay for the quantification of antibodies against hepatitis B virus surface antigen. Eur. J. Clin. Chem. Clin. Biochem. 34:365368.
14. Doern, G. V.,, L. Robbie,, and L. Marrama. 1994. Comparison of two enzyme immunoassays and two latex agglutination assays for detection of cytomegalovirus antibody. Diagn. Microbiol. Infect. Dis. 20:109112.
15. Doern, G. V.,, L. Robbie,, and R. St. Amand. 1997. Comparison of the Vidas and Bio-Whittaker enzyme immunoassays for detecting IgG reactive with varicella-zoster virus and mumps virus. Diagn. Microbiol. Infect. Dis. 28:3134.
16. Eble, K.,, J. Clemens,, C. Krenc,, M. Rynning,, J. Stojak,, J. Stuckmann,, P. Hutten,, L. Nelson,, L. DuCharme,, S. Hojvat,, and L. Mimms. 1991. Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays. J. Med. Virol. 33:139150.
17. Evans, R.,, and D. O. Ho-Yen. 2000. Evidence-based diagnosis of toxoplasma infection. Eur. J. Clin. Microbiol. Infect. Dis. 19:829833.
18. Fayol, V.,, and G. Ville. 1991. Evaluation of automated enzyme immunoassays for several markers for hepatitis A and B using the Abbott IMx analyzer. Eur. J. Clin. Chem. Clin. Biochem. 29:6770.
19. Fiore, M.,, J. Mitchell,, T. Doan,, R. Nelson,, G. Winter,, C. Grandone,, K. Zeng,, R. Haraden,, J. Smith,, K. Harris,, J. Leszczynski,, D. Berry,, S. Safford,, G. Barnes,, A. Scholnick,, and K. Ludington. 1988. The Abbott IMx automated benchtop immunochemistry analyzer system. Clin. Chem. 34:17261732.
20. Forest, J. C.,, J. Masse,, and A. Lane 1998. Evaluation of the analytical performance of the Boehringer Mannheim Elecsys 2010 immunoanalyzer. Clin. Biochem. 31:81-88.
21. Gangar, V.,, M. S. Curiale,, A. D’Onorio,, A. Schultz,, R. L. Johnson,, and V. Atrache. 2000. VIDAS enzyme-linked immunofluorescent assay for detection of Listeria in foods: collaborative study. J. AOAC Int. 83:903918.
22. Goossens, H.,, Y. Glupczynski,, A. Burette,, C. Van den Borre,, and J. P. Butzler. 1992. Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection. J. Clin. Microbiol. 30:176180.
23. Grangeot-Keros, L.,, and G. Enders. 1997. Evaluation of a new enzyme immunoassay based on recombinant rubella virus-like particles for detection of immunoglobulin M antibodies to rubella virus. J. Clin. Microbiol. 35:398401.
24. Grangeot-Keros, L.,, B. Pustowoit,, and T. Hobman. 1995. Evaluation of Cobas Core Rubella IgG EIA recomb, a new enzyme immunoassay based on recombinant rubella-like particles. J. Clin. Microbiol. 33:23922394.
25. Groen, J.,, B. Hersmus,, H. G. Niesters,, W. Roest,, G. van Dijk,, W. van der Meijden,, and A. D. Osterhaus. 1999. Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma. J. Clin. Virol. 12:193200.
26. Hadziyannis, E.,, W. Sholtis,, S. Schindler,, and B. Yen-Lieberman. 1999. Comparison of VIDAS with direct immunofluorescence for the detection of respiratory syncytial virus in clinical specimens. J. Clin. Virol. 14:133136.
27. Heijtink, R. A.,, J. Kruining,, P. Honkoop,, M. C. Kuhns,, W. C. Hop,, A. D. Osterhaus,, and S. W. Schalm. 1997. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B. J. Med. Virol. 53:282287.
28. Hendriks, H. A.,, W. Kortlandt,, and W. M. Verweij. 2000. Standardized comparison of processing capacity and efficiency of five new-generation immunoassay analyzers. Clin. Chem. 46:105111.
29. Hennig, H.,, P. Schlenke,, H. Kirchner,, I. Bauer,, B. Schulte-Kellinghaus,, and H. Bludau. 2000. Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies. J. Virol. Methods 84:181190.
30. Kerdahi, K. F.,, and P. F. Istafanos. 2000. Rapid determination of Listeria monocytogenes by automated enzyme-linked immunoassay and nonradioactive DNA probe. J. AOAC Int. 83:8688.
31. Lavanchy, D.,, J. Steinmann,, A. Moritz,, and P. C. Frei. 1996. Evaluation of a new automated third-generation anti-HCV enzyme immunoassay. J. Clin. Lab. Anal. 10:269276.
32. Lazzarotto, T.,, C. Galli,, R. Pulvirenti,, R. Rescaldani,, R. Vezzo,, A. La Gioia,, C. Martinelli,, S. La Rocca,, G. Agresti,, L. Grillner,, M. Nordin,, M. van Ranst,, B. Combs,, G. T. Maine,, and M. P. Landini. 2001. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin. Diagn. Lab. Immunol. 8:196198.
33. Lin, D. B.,, T. P. Tsai,, C. C. Yang,, H. M. Wang,, S. C. Yuan,, M. H. Cheng,, S. L. You,, and C. J. Chen. 2000. Current seroprevalence of hepatitis A virus infection among kindergarten children and teachers in Taiwan. Southeast Asian J. Trop. Med. Public Health 31:2528.
34. Liu, X.,, B. P. Turner,, C. E. Peyton,, B. S. Reisner,, A. O. Okorodudu,, A. A. Mohammad,, G. D. Hankins,, A. S. Weissfeld,, and J. R. Petersen. 2000. Prospective study of IgM to Toxoplasma gondii on Beckman Coulter’s Access ™ immunoassay system and comparison with Zeus ELISA and Gull IFA assays. Diagn. Microbiol. Infect. Dis. 36:237239.
35. Maine, G. T.,, R. Stricker,, M. Schuler,, J. Spesard,, S. Brojanac,, B. Iriarte,, K. Herwig,, T. Gramins,, B. Combs,, J. Wise,, H. Simmons,, T. Gram,, J. Lonze,, D. Ruzicki,, B. Byrne,, J. D. Clifton,, L. E. Chovan,, D. Wachta,, C. Holas,, D. Wang,, T. Wilson,, S. Tomazic-Allen,, M. A. Clements,, G. L. Wright,, T. Lazzarotto,, A. Ripalti,, and M. P. Landini. 2000. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J. Clin. Microbiol. 38:14761481.
36. Matter, L.,, and D. Germann. 1995. Detection of human immunodeficiency virus (HIV) type 1 antibodies by new automated microparticle enzyme immunoassay for HIV types 1 and 2. J. Clin. Microbiol. 33:23382341.
37. Ognibene, A.,, C. J. Drake,, K. Y. Jeng,, T. E. Pascucci,, S. Hsu,, F. Luceri,, and G. Messeri. 2000. A new modular chemiluminescence immunassay analyzer evaluated. Clin. Chem. Lab. Med. 38:251260.
38. Ostrow, D. H.,, B. Edwards,, D. Kimes,, J. Macioszek,, H. Irace,, L. Nelson,, K. Bartko,, J. Neva,, C. Krenc,, and L. Mimms. 1991. Quantitation of hepatitis B surface antibody by an automated microparticle enzyme immunoassay. J. Virol. Methods 32:265276.
39. Pelloux, H.,, E. Brun,, G. Vernet,, S. Marcillat,, M. Jolivet,, D. Guergour,, H. Fricker-Hidalgo,, A. Goullier-Fleuret,, and P. Ambroise-Thomas. 1998. Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bio-Merieux). Diagn. Microbiol. Infect. Dis. 32:6973.
40. Rao, L. V.,, O. A. James,, L. M. Mann,, A. A. Mohammad,, A. O. Okorodudu,, M. G. Bissell,, and J. R. Petersen. 1997. Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis. Diagn. Microbiol. Infect. Dis. 27:1315.
41. Ratnam, S.,, V. Gadag,, R. West,, J. Burris,, E. Oates,, F. Stead,, and N. Bouilianne. 1995. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J. Clin. Microbiol. 33:811815.
42. Robbins, D.,, T. Wright,, C. Coleman,, L. Umhoefer,, B. Moore,, A. Spronk,, C. Douville,, I. K. Kuramoto,, M. Rynning,, D. Gracey,, V. Salbilla,, F. Nehmadi,, and L. T. Mimms. 1992. Serological detection of HBeAg and anti-HBe using automated microparticle enzyme immunoassays. J. Virol. Methods 38:267281.
43. Robbins, D. J.,, J. Krater,, W. Kiang,, X. Alcalde,, S. Helgesen,, J. Carlos,, and L. Mimms. 1991. Detection of total antibody against hepatitis A virus by an automated microparticle enzyme immunoassay. J. Virol. Methods 32:255263.
44. Safford, J. W.,, G. G. Abbott,, M. C. Craine,, and R. G. MacDonald. 1991. Automated microparticle enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii. J. Clin. Pathol. 44:238242.
45. Sandin, R. L.,, C. C. Knapp,, G. S. Hall,, J. A. Washington,, and I. Rutherford. 1991. Comparison of the Vitek Immunodiagnostic Assay System with an indirect immunoassay (Toxostat Test Kit) for detection of immunoglobulin G antibodies to Toxoplasma gondii in clinical specimens. J. Clin. Microbiol. 29:27632767.
46. Schachter, J.,, R. B. Jones,, R. C. Butler,, B. Rice,, D. Brooks,, B. Van der Pol,, M. Gray,, and J. Moncada. 1997. Evaluation of the Vidas Chlamydia test to detect and verify Chlamydia trachomatis in urogenital specimens. J. Clin. Microbiol. 35:21022106.
47. Schaefer, L. E.,, J. W. Dyke,, F. D. Meglio,, P. R. Murray,, W. Crafts,, and A. C. Niles. 1989. Evaluation of microparticle enzyme immunoassays for immunoglobulins G and M to rubella virus and Toxoplasma gondii on the Abbott IMx automated analyzer. J. Clin. Microbiol. 27:24102413.
48. Shanholtzer, C. J.,, K. E. Willard,, J. J. Holter,, M. M. Olson,, D. N. Gerding,, and L. R. Peterson 1992. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J. Clin. Microbiol. 30:18371840.
49. Smith, J.,, and G. Osikowicz 1993. Abbott AxSYM random and continuous access immunoassay system for improved workflow in the clinical laboratory. Clin. Chem. 39:20632069.
50. Steinmann, J.,, and T. Weigel. 1994. Comparison of two Cobas Core enzyme immunoassays with other test systems for the detection of cytomegalovirus-specific IgG and IgM antibodies. J. Clin. Lab. Anal. 8:191199.
51. Tang, Y. W.,, J. A. Helgason,, A. D. Wold,, and T. F. Smith. 1998. Detection of Epstein-Barr virus-specific antibodies by an automated enzyme immunoassay. Performance evaluation and cost analysis. Diagn. Microbiol. Infect. Dis. 31:549554.
52. Tholcken, C. A., and G. L. Woods. 2000. Evaluation of the Bio-Rad syphilis IgG test performed on the CODA system for serologic diagnosis of syphilis. Diagn. Microbiol. Infect. Dis. 37:157160.
53. Van Der Ende, A.,, R. W. van Der Hulst,, P. Roorda,, G. N. Tytgat,, and J. Dankert. 1999. Evaluation of three commerical serological tests with different methodologies to assess Helicobacter pylori infection. J. Clin. Microbiol. 37:41504152.
54. Vernozy-Rozand, C.,, C. Mazuy,, G. Prevost,, C. Lapeyre,, M. Bes,, Y. Brun,, and J. Fleurette. 1996. Enterotoxin production by coagulase-negative staphylococci isolated from goats’ milk and cheese. Int. J. Food Microbiol. 30:271280.
55. Vernozy-Rozand, C.,, C. Mazuy,, S. Ray-Gueniot,, S. Boutrand-Loei,, A. Meyrand,, and Y. Richard. 1998. Evaluation of the VIDAS methodology for detection of Escherichia coli O157 in food samples. J. Food Prot. 61:917920.
56. Weber, B.,, A. Bayer,, P. Kirch,, V. Schluter,, D. Schlieper,, and W. Melchior. 1999. Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J. Clin. Microbiol. 37:26392647.
57. Weber, B.,, A. Muhlbacher,, U. Michl,, G. Paggi,, V. Bossi,, C. Sargento,, R. Camacho,, E. H. Fall,, A. Berger,, U. Schmitt,, and W. Melchior. 1999. Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay. J. Virol. Methods 78:6170.
58. Weber, B.,, E. H. Fall,, A. Berger,, and H. W. Doerr. 1998. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assay. J. Clin. Microbiol. 36:22352239.
59. Weber, B.,, N. Behrens,, and H. W. Doerr. 1997. Detection of human immunodeficiency virus type 1 and type 2 antibodies by a new automated microparticle immunoassay AxSYM HIV-1/HIV-2. J. Virol. Methods 63:137143.

Tables

Generic image for table
TABLE 1

Automated immunoassay systems for viral, bacterial, fungal, and parasitic antibody and antigen detection

Citation: Hodinka R. 2002. Automated Immunoassay Analyzers, p 324-335. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch13

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error